Read more

April 22, 2020
1 min read
Save

Top stories in endocrinology: Endocrine-related targets may guide COVID-19 treatments, updates in Prader-Willi syndrome

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

In a recent interview, Alice C. Levine, MD, professor of medicine, endocrinology, diabetes and bone disease at the Icahn School of Medicine at Mount Sinai, New York, spoke with Healio about how antiandrogen treatments could potentially improve — or worsen — COVID-19 outcomes. It was the top story in endocrinology last week.

Another top story was a review on diagnosing and treating Prader-Willi syndrome, the most common genetic cause of life-threatening childhood obesity.

Read these and more top stories in endocrinology below:

Endocrine-related targets may drive treatments for COVID-19

As research on COVID-19 continues, endocrinologists are focusing on the mechanism of entry of the virus into cells — angiotensin-converting enzyme 2, which has been established as the COVID-19 receptor; however, data are conflicting regarding its translational relevance. Read more.

'More hopeful outcomes' on the horizon for Prader-Willi syndrome

Prader-Willi syndrome, a neurodevelopmental disorder that occurs in about 1 in 15,000 births, is the most common genetic cause of life-threatening childhood obesity, which is just one of its complex symptoms. Still, it has proved extremely difficult to treat. Fortunately for the Prader-Willi syndrome community, researchers continue to test potential therapies to find a comprehensive treatment or a way to curb the most severe symptoms. Read more.

Obesity baby boy 2020 
Prader-Willi syndrome, a neurodevelopmental disorder that occurs in about 1 in 15,000 births, is the most common genetic cause of life-threatening childhood obesity, which is just one of its complex symptoms.
Source: Adobe Stock

Endocrinology community remembers Alan J. Garber, MD, PhD, MACE

Alan J. Garber, MD, PhD, MACE, a leading expert on diabetes and cardiometabolic disorders and long-time chief medical editor of Endocrine Today, died Thursday, April 9. Read more.

Adopting vegetarian diet can be easy, offer cardiometabolic benefits

Whether the motivation is animal or worker welfare, environmental sustainability, personal taste or something else, people with diabetes can safely adopt a plant-based diet. In fact, vegetarian and vegan eating patterns have been shown to improve cardiovascular disease and glucose management. Read more.

BLOG: Death in the time of coronavirus

Saleh Aldasouqi, MD, FACE, ECNU, shares stories exemplifying how “painful” death is for family members and friends of COVID-19 victims. Read more.